| MEDFX | PAIKX | MEDFX / PAIKX | |
| Total Expense Ratio | 1.07 | 1.15 | 93% |
| Annual Report Gross Expense Ratio | 1.08 | 2.97 | 36% |
| Fund Existence | 18 years | 11 years | - |
| Gain YTD | 2.817 | 3.480 | 81% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2500 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 7.64B | 6.27B | 122% |
| Annual Yield % from dividends | 5.16 | 5.47 | 94% |
| Returns for 1 year | 10.12 | 12.07 | 84% |
| Returns for 3 years | 31.45 | 35.86 | 88% |
| Returns for 5 years | 13.62 | 13.71 | 99% |
| Returns for 10 years | 42.14 | 32.89 | 128% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| TROZX | 26.65 | 0.50 | +1.91% |
| T. Rowe Price International Value Eq Z | |||
| EPSPX | 29.17 | 0.17 | +0.59% |
| NYLI Epoch Global Equity Yield Class A | |||
| TRNEX | 45.84 | 0.27 | +0.59% |
| T. Rowe Price New Era I | |||
| EAFVX | 24.26 | 0.12 | +0.50% |
| Eaton Vance Focused Value Opps A | |||
| SUSIX | 14.18 | 0.03 | +0.21% |
| State Street Instl US Equity Inv | |||